Company Profile
Evelo Biosciences Stock Price, News & Analysis
- Ticker:
- EVLO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (-99.00%)
Close
Last updated: August 4, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for EVLO.
Company overview
Business overview
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker. Its story was centered on the challenge of turning a novel biology concept into durable human data.
Geographic Base and Sector Classification
Evelo was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotechnology and immunology.
Business Model Characteristics
The company depended on translational validation, clinical data, and access to capital. Investors historically watched whether the platform could show enough differentiation to survive in a crowded biotech market.
Position Within the Biotechnology Landscape
Evelo is best viewed as a historical platform-biotech name. Its valuation was always tied to science proof and capital runway more than commercial scale.
Future catalysts
Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on what value remains.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Evelo Biosciences (EVLO)?
Evelo Biosciences (EVLO) most recently closed at 0.00 USD, a -99.00% move versus the previous session.
What does Evelo Biosciences do?
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker. Its story was centered on the challenge of turning a novel biology concept into durable human data.
On which exchange is EVLO stock listed?
Evelo Biosciences (EVLO) is associated with NASDAQ, United States, Biopharma.
What is Evelo?
Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.
Which conditions is Evelo Biosciences targeting with Evelo?
Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.
How does Evelo Biosciences describe recent progress with Evelo?
Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.
What is Biosciences?
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker.
What should investors watch for with Biosciences?
Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.